Cargando…

Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential

PURPOSE: Safety and efficiency are critical for successful gene therapy. Adeno-associated viral (AAV) vectors are commonly used for gene transfer in both human and animal studies. However, administration of AAV vectors can lead to development of neutralizing antibodies against the vector capsid, thu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qiuhong, Miller, Rehae, Han, Ping-Yang, Pang, Jijing, Dinculescu, Astra, Chiodo, Vince, Hauswirth, William W.
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Vision 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559816/ https://www.ncbi.nlm.nih.gov/pubmed/18836574

Ejemplares similares

Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines
por: Ryals, Renee C., et al.
Publicado: (2011)

AAV-Mediated Clarin-1 Expression in the Mouse Retina: Implications for USH3A Gene Therapy
por: Dinculescu, Astra, et al.
Publicado: (2016)

Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye
por: Li, Wensheng, et al.
Publicado: (2009)

Cone Phosphodiesterase-6γ’ Subunit Augments Cone PDE6 Holoenzyme Assembly and Stability in a Mouse Model Lacking Both Rod and Cone PDE6 Catalytic Subunits
por: Deng, Wen-Tao, et al.
Publicado: (2018)

Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
por: Mowat, FM, et al.
Publicado: (2013)

AAV retinal transduction in a large animal model species: Comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vector
por: Petersen-Jones, S.M., et al.
Publicado: (2009)

Review: The history and role of naturally occurring mouse models with Pde6b mutations
por: Han, Juanjuan, et al.
Publicado: (2013)

Systemic and local immune responses to intraocular AAV vector administration in non-human primates
por: Ail, Divya, et al.
Publicado: (2022)

Next-generation sequencing of mitochondrial targeted AAV transfer of human ND4 in mice
por: Yu, Hong, et al.
Publicado: (2013)

rAAV2/5 gene-targeting to rods: dose-dependent efficiency and complications associated with different promoters
por: Beltran, William A., et al.
Publicado: (2010)

Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy
por: Deng, Wen-Tao, et al.
Publicado: (2018)

Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?
por: Bey, Karim, et al.
Publicado: (2020)

Humoral Immune Response to AAV
por: Calcedo, Roberto, et al.
Publicado: (2013)

Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue
por: Mingozzi, F, et al.
Publicado: (2013)

CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain
por: Mathiesen, Sophie N., et al.
Publicado: (2020)

AAV-Mediated Cone Rescue in a Naturally Occurring Mouse Model of CNGA3-Achromatopsia
por: Pang, Ji-jing, et al.
Publicado: (2012)

Correction: AAV-Mediated Cone Rescue in a Naturally Occurring Mouse Model of CNGA3-Achromatopsia
por: Pang, Ji-jing, et al.
Publicado: (2014)

Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I
por: Belur, Lalitha R., et al.
Publicado: (2021)

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes
por: Adu-Agyeiwaah, Yvonne, et al.
Publicado: (2023)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice
por: Iwata, Nobuhisa, et al.
Publicado: (2013)

Overcoming the Challenges Imposed by Humoral Immunity to AAV Vectors to Achieve Safe and Efficient Gene Transfer in Seropositive Patients
por: Gross, David-Alexandre, et al.
Publicado: (2022)

Pharmacological and rAAV Gene Therapy Rescue of Visual Functions in a Blind Mouse Model of Leber Congenital Amaurosis
por: Batten, Matthew L, et al.
Publicado: (2005)

Characterization of Naturally-Occurring Humoral Immunity to AAV in Sheep
por: Tellez, Joseph, et al.
Publicado: (2013)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Retinal Gene Therapy for Usher Syndrome: Current Developments, Challenges, and Perspectives
por: Dinculescu, Astra, et al.
Publicado: (2021)

AAV vector distribution in the mouse respiratory tract following four different methods of administration
por: Santry, Lisa A., et al.
Publicado: (2017)

Recombinant AAV-Mediated BEST1 Transfer to the Retinal Pigment Epithelium: Analysis of Serotype-Dependent Retinal Effects
por: Guziewicz, Karina E., et al.
Publicado: (2013)

Lack of Humoral Immune Response to the Tetracycline (Tet) Activator in Rats Injected Intracranially with Tet-off rAAV Vectors
por: Han, Ye, et al.
Publicado: (2010)

Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood
por: Smith, Corinne J., et al.
Publicado: (2022)

Caspase Inhibition with XIAP as an Adjunct to AAV Vector Gene-Replacement Therapy: Improving Efficacy and Prolonging the Treatment Window
por: Yao, Jingyu, et al.
Publicado: (2012)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

Chemically Defined, High-Density Insect Cell-Based Expression System for Scalable AAV Vector Production
por: Kurasawa, James H., et al.
Publicado: (2020)

Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors
por: Kay, Christine N., et al.
Publicado: (2013)

Innate Immune Responses to AAV Vectors
por: Rogers, Geoffrey L., et al.
Publicado: (2011)

AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020)

AAV gene therapy vectors in the TMJ
por: Brouxhon, Sabine M., et al.
Publicado: (2022)

Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
por: Skorput, Alexander G. J., et al.
Publicado: (2022)

Rescue of cone function in cone-only Nphp5 knockout mouse model with Leber congenital amaurosis phenotype
por: Hanke-Gogokhia, Christin, et al.
Publicado: (2018)

Correction: Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors
por: Kay, Christine N., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_osq0sch6qn8l37rijnavugvmot